1.
J Med Chem
; 51(22): 7049-52, 2008 Nov 27.
Article
in English
| MEDLINE
| ID: mdl-18942827
ABSTRACT
A series of arylaminobenzimidazoles was designed and synthesized as Raf kinase inhibitors. Exploration of the structure-activity relationship resulted in compounds that are potent in vitro and show desirable in vivo properties.